BioLineRx Ltd. (BLRX) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biolinerx Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.115 -- 00:00:02.980 Ladies and gentlemen, thank you for standing by. 00:00:02.980 -- 00:00:08.288 Welcome to BioLineRx first quarter 2025 financial results conference call. 00:00:08.288 -- 00:00:11.894 All participants are presently in a listen-only mode. 00:00:11.894 -- 00:00:16.301 Following management's formal presentation, instructions will be given for the question 00:00:16.301 -- 00:00:22.151 and answer session. I would now like to turn over the call to Irena Koffler, 00:00:22.151 -- 00:00:23.854 investor relations. 00:00:23.854 -- 00:00:28.282 Irena, please go ahead. Thank you operator and welcome everyone. 00:00:28.282 -- 00:00:33.210 Thank you for joining us on our quarterly results conference call. 00:00:33.210 -- 00:00:38.479 Earlier today we issued a press release, a copy of which is available in the investor 00:00:38.479 -- 00:00:44.670 relations section of our website. It was also filed as a 6K. 00:00:44.670 -- 00:00:49.237 I'd like to remind you that certain statements we make during the call will be forward 00:00:49.237 -- 00:00:54.368 looking. Because such statements deal with future events and are subject to many 00:00:54.368 -- 00:00:56.612 risks and uncertainties, 00:00:56.612 -- 00:01:01.459 actual results may differ materially from those in the forward-looking statements. 00:01:01.459 -- 00:01:06.667 For a full discussion of these risks and uncertainties, please review our annual 00:01:06.667 -- 00:01:09.331 report on Form 20F 00:01:09.331 -- 00:01:14.158 and our quarterly reports on Form 6K that are filed with the U.S. 00:01:14.158 -- 00:01:19.270 Securities and Exchange Commission. At this time, it is now my pleasure to 00:01:19.270 -- 00:01:25.595 turn the call over to Mr. Phil Serlin, Chief Executive Officer of BioLineRx. 00:...